Fundz

Restart Life acquires Holy Crap Foods

PRIVATEFeb 27, 2026

Acquiring Company

Restart Life Sciences

Acquired Company

Holy Crap Foods

VancouverBiotechnologyHealth CareLife ScienceDietary SupplementsNutrition

Description

Restart Life Sciences Corp. has completed its acquisition of Holy Crap Foods Inc., securing 100% of its shares. This strategic move adds over $1 million in annual revenue for Restart Life and enhances its standing in the health sector. Holy Crap now operates as a wholly owned subsidiary, with plans for operational continuity and growth. The acquisition includes all aspects of Holy Crap's business ecosystem and manufacturing operations.

Quick answer

Restart Life Sciences is acquiring Holy Crap Foods, announced February 27, 2026. Restart Life Sciences is based in Vancouver, British Columbia, Canada.

How much did Restart Life Sciences pay for Holy Crap Foods?
The deal value was not disclosed.
What does Restart Life Sciences do?
Restart Life Sciences is a biopharmaceutical company focused on developing innovative therapies.
Where are Restart Life Sciences and Holy Crap Foods based?
Restart Life Sciences is based in Vancouver, British Columbia, Canada.

Source: Fundz verified event record.

Other recent acquisitions in Life Science and Dietary Supplements

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Restart Life Sciences, and when

When Restart Life Sciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Restart Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Restart Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Restart Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Restart Life Sciences

Location

Vancouver, British Columbia, Canada

About

Restart Life Sciences is a biopharmaceutical company focused on developing innovative therapies. The company aims to improve health outcomes through strategic acquisitions and operational improvements. Its subsidiary enhances its portfolio with new growth initiatives and operational efficiency. Restart is committed to scalable, long-term growth in the healthcare sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Restart Life Sciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Restart Life Sciences's next move

Learn about Strategic plan

Frequently asked

Who acquired Holy Crap Foods?

Holy Crap Foods was acquired by Restart Life Sciences, based in Vancouver. The deal was reported on February 27, 2026. Restart Life Sciences is a biopharmaceutical company focused on developing innovative therapies. The company aims to improve health outcomes through strategic acquisitions and operational improvements. Restart Life Sciences is privately held and operates in Biotechnology.

When did Restart Life Sciences acquire Holy Crap Foods?

Restart Life Sciences's acquisition of Holy Crap Foods was reported on February 27, 2026. Restart Life Sciences Corp. has completed its acquisition of Holy Crap Foods Inc., securing 100% of its shares. This strategic move adds over $1 million in annual revenue for Restart Life and enhances its standing in the health sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Holy Crap Foods do?

Holy Crap Foods is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.